Pfizer gets FDA approval to use its breast cancer drug for more patients with advanced disease.

PFE · Pfizer Inc.

The AI's read

This may let Pfizer offer TUKYSA to more people earlier in care, creating room for wider use. Patients in the study went longer before their cancer worsened than those on the comparison treatment. The article also mentions a Florida lawsuit about vaccine safety claims and a weakening short-term price signal. Those points raise separate concerns, but do not undo the cancer-drug result.